不要做出錯誤決斷。
我不相信控制價格,能讓人得到好的醫療品質
健保署首訂醫材「自付差額」上限 九成自付差額醫材都將降價」
單種產品的品質跟價格,差異本來就很大,從樂器、食品、到醫療器材都是如此。
許多苛求食材、樂器到重視醫療器材品質的廠商,要花多少時間去反覆驗證,確保給消費著最好品質的服務;而這些,難道不需要資金、不需要人才去努力?
當所有周邊商品也全面「基礎化」;那也就沒有差異化。
只要關於醫療,不論是服務或是耗材,它的價格訂定的基本線應該是專業的know how,而醫材這個部分是有專利的,能夠壓的下價錢的都是過了專利期限的商品。
如果有了上限,在健保的使用藥品就會,第一,產品選擇有限,第二,台廠制。畢竟,價格決定廠商要給你什麼樣的藥。
然後,就會再出現一個問題,醫師想用好的藥材跟器材,就會開給病患另一個自費的選擇。這是現在在醫院比較普遍的現象。
我們在許多原廠藥跟好的醫材已經越來越來少、議價狀況也越來越不佳;如果逆市場機制,最後傷害的還是全民。
逆市場機制的非常作為,是要在對大眾有立即性危害,應該有緊急性、局限性、時效性(比方說因應疫情口罩);不能更不該常態化。
真誠希望政府不該干預市場機制,而是讓資訊透明,市場機制運作的更順利。
Don’t make wrong decisions.
I don’t believe that controlled prices will guarantee good health care.
The National Health Insurance Department head first sets the upper limit for the "deductible balance" for medical materials at 90% of the deductible. Medical materials are then all at this reduced price.
The difference between the quality and price of a single product is very large in areas such as musical instruments, food, and medical equipment.
Many manufacturers of food ingredients, musical instruments, medical equipment all have to pay attention to quality. How much time does it takes to repeatedly verify and ensure that the best quality service is consumed; and do these not also need capital and hardworking employees?
When all surrounding commodities are fully "basic", there is no differentiation.
As long as it is related to medical care, whether it is service or consumables, the basic line for its price setting should be based on professional expertise for patented medical materials. The prices can then be reduced for all products that have passed the patent period.
If there is an upper limit, the use of drugs in health insurance will first cause limited product choices, and then second cause an only Taiwan-made system. After all, the price determines what kind of medicine the manufacturer wants to give you.
Then, there will be another problem. Let’s say the doctor wants to use good medicines and equipment, they often will give the patient another option that’s available at his or her own expense. This is a relatively common phenomenon in hospitals.
Many of our original medicines and good medical materials options have continually decreased, and bargaining conditions are getting worse and worse. If the market mechanism is reversed, it will ultimately hurt everyone.
The counter-market mechanism is very effective in that it can respond to an immediate harm to the public and should be reserved for urgent, limited, and time-sensitive responses (for example, the mask production in response to the epidemic). This response should not be the norm.
I hope that the government doesn’t intervene in the market mechanism, but instead works to make information transparent and operate smoother for this industry.